Teagan E Marshall
Overview
Explore the profile of Teagan E Marshall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greenspun B, Metzger D, Foshag A, Marshall T, Pearson B, Zarnegar R, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40048027
No abstract available.
2.
Greenspun B, Metzger D, Foshag A, Marshall T, Pearson B, Zarnegar R, et al.
Ann Surg Oncol
. 2025 Jan;
PMID: 39888466
Background: Guidelines for some pancreatic neuroendocrine tumors (NETs) have shifted towards active surveillance given the indolent nature of this malignancy. We sought to assess the safety of delayed surgery on...
3.
Greenspun B, Lee-Saxton Y, Egan C, Marshall T, Tumati A, Pearson B, et al.
Am J Surg
. 2025 Jan;
242:116194.
PMID: 39823654
The benefit of adjuvant radiation therapy (RT) in adrenocortical carcinoma (ACC) is not well characterized for those who undergo initial R0 surgical resection. Patients in the NCDB who underwent R0...
4.
Palacardo F, Lee-Saxton Y, Tumati A, Marshall T, Greenspun B, Zarnegar R, et al.
Ann Surg Oncol
. 2024 Nov;
32(3):1725-1726.
PMID: 39586951
No abstract available.
5.
Palacardo F, Lee-Saxton Y, Tumati A, Marshall T, Greenspun B, Zarnegar R, et al.
Ann Surg Oncol
. 2024 Nov;
32(3):1698-1708.
PMID: 39505729
Background: The association of radioactive iodine (RAI) with disease-specific survival (DSS) is controversial in N1b papillary thyroid carcinoma (PTC). We aimed to evaluate whether RAI is associated with DSS in...
6.
Greenspun B, Chirko D, Toor R, Wierzbicki K, Marshall T, Tumati A, et al.
Surgery
. 2024 Oct;
178():108886.
PMID: 39428280
Background: Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with limited treatment options. Although there have been recent advancements revealing genomic drivers of these tumors, it remains unclear which...
7.
Tumati A, Marshall T, Greenspun B, Chen Z, Azar S, Keutgen X, et al.
Surgery
. 2024 Oct;
177():108833.
PMID: 39394019
Background: Integrating microRNA markers with next-generation sequencing panels may enhance risk assessment of cytologically indeterminate thyroid nodules. The ThyGeNEXT-ThyraMIRv1 multiplatform test version 1 demonstrated limited utility in risk-stratifying RAS-mutated indeterminate...
8.
Marshall T, Ibrahim R, Lee-Saxton Y, Tumati A, Hubbs D, Zarnegar R, et al.
Am J Surg
. 2024 Sep;
238:115944.
PMID: 39340869
Background: Anaplastic thyroid cancer (ATC) is highly aggressive with a poor prognosis. Adjuvant systemic therapy and radiation post-surgery are endorsed by NCCN and ATA guidelines. Our study aimed to identify...
9.
Marshall T, Alqamish M, Salehi N, Al Asadi H, Lee-Saxton Y, Tumati A, et al.
Surg Endosc
. 2024 Jul;
38(9):5285-5291.
PMID: 39009731
Introduction: As our population ages, older adults are being considered for anti-reflux surgery (ARS). Geriatric patients typically have heightened surgical risk, and literature has shown mixed results regarding postoperative outcomes....
10.
Lee-Saxton Y, Palacardo F, Greenberg J, Egan C, Marshall T, Tumati A, et al.
Surgery
. 2024 Apr;
175(1):215-220.
PMID: 38563429
Background: We aimed to evaluate the impact of radioactive iodine on disease-specific survival in intrathyroidal (N0M0) papillary thyroid carcinoma >4 cm, given conflicting data in the American Thyroid Association guidelines...